Sharekhan

Aarti Pharmalabs Ltd

Mon 1/12/2025,12:9:57 NSE: AARTIPHARM

₹ 701.00 0.35 (0.05%)
BUY NOW Buy Aarti Pharmalabs Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Aarti Pharmalabs Ltd

Mon 1/12/2025,12:12:0

Aarti Pharmalabs Ltd

Mon 1/12/2025,12:9:57 | NSE : AARTIPHARM

₹ 701.000.35 (0.05%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 697.10

Previous Close

₹ 700.65

Volume

57897

Mkt Cap ( Rs. Cr)

₹6354.38

High

₹ 703.25

Low

₹ 692.50

52 Week High

₹ 971.00

52 Week Low

₹ 557.05

Book Value Per Share

₹ 204.83

Dividend Yield

0.00

Face Value

₹ 5.00

What’s Your Call?

Collective community sentiment on Aarti Pharmalabs Ltd

Your Vote -

Buy

90.00%

Hold

0.00%

Sell

10.00%

90.00%

10 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

43%

Sell Order Quantity

57%

Bid Price

Qty

700.00

100

700.00

3

700.00

1

700.00

5

700.00

17

Bid Total

28744

Bid Price

Qty

700.45

9

700.00

10

701.00

17

701.00

20

701.00

10

Bid Total

38843

Option Chain

Analyzes market sentiment, predicts Aarti Pharmalabs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Nov 2025, 5:37PM Aarti Pharmalabs Limited has informed the Exchange about Transcript

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    17 Nov 2025, 5:29PM Transcript of Q2 FY 26 Earnings Conference Call.

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    11 Nov 2025, 6:43PM Recording of the Earnings Conference call for Q2 FY 26

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Nov 2025, 6:24PM Aarti Pharmalabs Limited has informed the Exchange about Link of Recording

  • Aarti Pharmalabs - Copy of Newspaper Publication

    11 Nov 2025, 2:47PM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

  • Aarti Pharmalabs - Investor Presentation

    11 Nov 2025, 8:23AM Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation

    11 Nov 2025, 8:18AM Investor Presentation for Q2 FY 26

  • Aarti Pharmalabs Q2 net profit down 35.35% at Rs 30.93 cr

    10 Nov 2025, 9:01AM The company reported standalone net profit of Rs 30.93 crore for the quarter ended September 30, 2025 as compared to Rs 47.84 crore in the same period

  • Aarti Pharmalabs - Outcome of Board Meeting

    9 Nov 2025, 3:32PM Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

  • Aarti Pharmalabs - Change in Management

    9 Nov 2025, 2:06PM Aarti Pharmalabs Limited has informed the Exchange about change in Management

  • Aarti Pharmalabs - Financial Results For Quarter And Half Year Ended September 30, 2025

    9 Nov 2025, 4:27PM Please find enclosed.

  • Aarti Pharmalabs - Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended

    9 Nov 2025, 3:26PM Please find enclosed.

  • Aarti Pharmalabs - Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended

    9 Nov 2025, 3:25PM Please find enclosed.

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Change in Management

    9 Nov 2025, 2:03PM Please find enclosed.

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Nov 2025, 6:31PM Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet on Tuesday, November 11, 2025 at 4:00 P.M. (IST) to discuss the Company's Q2

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Nov 2025, 6:22PM This is to inform you that the Earnings Conference Call for Investors and Analysts, which would be a Group meet, has been scheduled on Tuesday, Novemb

  • Aarti Pharmalabs - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Standalone And Consolidate

    27 Oct 2025, 4:37PM Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2025 ,inter alia, to consider and

  • Aarti Pharmalabs has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    16 Oct 2025, 4:50PM As of September 2025, 42.88% is owned by Promoters and 57.12% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 42.71% and

  • Aarti Pharmalabs - Reply to Clarification- Financial results

    15 Oct 2025, 3:28PM The Exchange had sought clarification from Aarti Pharmalabs Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listi

  • Aarti Pharmalabs - ESOP/ESOS/ESPS

    13 Oct 2025, 7:34PM Aarti Pharmalabs Limited has informed the Exchange regarding Allotment of 6070 Shares.

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    13 Oct 2025, 7:16PM Please find enclosed.

  • Aarti Pharmalabs - General Updates

    8 Oct 2025, 10:59AM Aarti Pharmalabs Limited has informed the Exchange about General Updates

  • Aarti Pharmalabs Ltd gets interim patent-Infringement Injunction from Delhi High Court

    8 Oct 2025, 11:05AM Aarti Pharmalabs Ltd informed the stock exchanges that it has received an ex-parte ad-interim injunction from the Hon&rsquo;ble High Court of Delhi re

  • Aarti Pharmalabs - Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or R

    8 Oct 2025, 10:57AM Please find enclosed disclosure under Regulation 30 SEBI LODR, 2015.

  • Aarti Pharmalabs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Oct 2025, 11:14PM Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Aarti Pharmalabs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Oct 2025, 6:25PM Please find enclosed.

  • Aarti Pharmalabs - Trading Window

    25 Sep 2025, 3:41PM Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Aarti Pharmalabs - Investor Presentation

    23 Sep 2025, 7:57PM Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation

    23 Sep 2025, 7:54PM Please find enclosed

  • Aarti Pharmalabs - Change in Management

    23 Sep 2025, 7:44PM Aarti Pharmalabs Limited has informed the Exchange about change in Management

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Change in Management

    23 Sep 2025, 7:36PM Please find enclosed.

  • Aarti Pharmalabs - Shareholders meeting

    23 Sep 2025, 6:37PM Aarti Pharmalabs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2025

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2025, 6:25PM Scrutinizers Report and Voting Result of 6th Annual General Meeting.

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2025, 6:25PM Scrutinizers Report and Voting Result of 6th Annual General Meeting.

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2025, 6:25PM Scrutinizers Report and Voting Result of 6th Annual General Meeting.

  • Aarti Pharmalabs - Shareholders meeting

    22 Sep 2025, 4:02PM Aarti Pharmalabs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2025

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    23 Sep 2025, 6:25PM Scrutinizers Report and Voting Result of 6th Annual General Meeting.

  • Aarti Pharmalabs - Shareholder Meeting / Postal Ballot-Outcome of AGM

    22 Sep 2025, 3:44PM Proceedings of 6th Annual General Meeting

  • Aarti Pharmalabs - Copy of Newspaper Publication

    18 Sep 2025, 5:20PM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Sep 2025, 1:40PM Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Sep 2025, 1:37PM Please find enclosed

  • Aarti Pharmalabs - Clarification - Financial Results

    8 Sep 2025, 3:29PM The Exchange has sought clarification from Aarti Pharmalabs Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listi

  • Aarti Pharmalabs - Commencement of commercial production/operations

    3 Sep 2025, 2:30PM Aarti Pharmalabs Limited has informed the Exchange about Commencement of commercial production/operations

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    3 Sep 2025, 2:25PM Please find attached Press Release dated September 03, 2025
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Aarti Pharmalabs Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 2238.7261 1872.2571 1645.2909 1608.9004
Liabilities 2238.7261 1872.2571 1645.2909 1608.9004
Equity 45.3173 45.313 45.313 45.563
Gross Profit 426.5433 346.1585 308.3352 179.7858
Net Profit 257.3488 200.6454 171.7268 106.7261
Cash From Operating Activities 340.0057 183.6944 228.6894 -64.8426
NPM(%) 14.52 13.35 11.36 11.34
Revenue 1771.3518 1502.1319 1511.2478 941.021
Expenses 1344.8085 1155.9734 1202.9126 761.2352
ROE(%) 13.86 10.8 9.24 5.74

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
15 Sep 2025 2.5 50 0 799.45
14 Feb 2025 2.5 50 0 636.3
31 Jul 2024 1 20 0 520.05
2 40 0 557.85

Peers

Other companies within the same industry or sector that are comparable to Aarti Pharmalabs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 867.10 0.52 17.31 6315.89 337.37 1.04
Amines and Plasticizers Ltd 197.00 0.16 29.98 3851.68 372.61 0.25
Indogulf Cropsciences Ltd 87.55 -0.93 10.45 1646.43 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 34.71 31741.11 346.70 0.43

Company Info

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.

Read More

Parent Organisation

Aarti Pharmalabs Ltd.

Founded

22/11/2019

Managing Director

Mr.Narendra J Salvi

NSE Symbol

AARTIPHARMEQ

FAQ

The current price of Aarti Pharmalabs Ltd is ₹ 701.00.

The 52-week high for Aarti Pharmalabs Ltd is ₹ 703.25 and the 52-week low is ₹ 692.50.

The market capitalization of Aarti Pharmalabs Ltd is currently ₹ 6354.38. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aarti Pharmalabs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aarti Pharmalabs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aarti Pharmalabs Ltd shares.

The CEO of Aarti Pharmalabs Ltd is Mr.Narendra J Salvi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT